Jonathan D Zurawski, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 15 | 2023 | 3079 | 1.820 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 5 | 2022 | 520 | 1.300 |
Why?
|
| Meninges | 2 | 2019 | 190 | 1.150 |
Why?
|
| Meningitis | 1 | 2017 | 216 | 0.510 |
Why?
|
| Tolosa-Hunt Syndrome | 1 | 2013 | 2 | 0.480 |
Why?
|
| Immunologic Factors | 3 | 2020 | 1582 | 0.460 |
Why?
|
| Drug Substitution | 1 | 2016 | 281 | 0.460 |
Why?
|
| Ophthalmoplegia | 1 | 2013 | 166 | 0.420 |
Why?
|
| Rare Diseases | 1 | 2013 | 553 | 0.320 |
Why?
|
| Disability Evaluation | 4 | 2020 | 1828 | 0.310 |
Why?
|
| Headache | 1 | 2013 | 1226 | 0.260 |
Why?
|
| Cognition Disorders | 1 | 2020 | 4041 | 0.260 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15538 | 0.240 |
Why?
|
| Quality of Life | 4 | 2021 | 12805 | 0.240 |
Why?
|
| Disease Progression | 2 | 2021 | 13280 | 0.220 |
Why?
|
| Familial Mediterranean Fever | 1 | 2023 | 61 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2023 | 35423 | 0.200 |
Why?
|
| Demyelinating Diseases | 1 | 2023 | 363 | 0.190 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 236 | 0.170 |
Why?
|
| Atrophy | 2 | 2022 | 1582 | 0.160 |
Why?
|
| Brain | 5 | 2023 | 26413 | 0.150 |
Why?
|
| Interferon-beta | 1 | 2018 | 323 | 0.140 |
Why?
|
| Computers | 1 | 2018 | 611 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2016 | 23337 | 0.120 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 13990 | 0.120 |
Why?
|
| Meningitis, Aseptic | 1 | 2014 | 59 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 2 | 2010 | 1364 | 0.120 |
Why?
|
| Middle Aged | 12 | 2022 | 213367 | 0.120 |
Why?
|
| Vaccines | 1 | 2022 | 822 | 0.110 |
Why?
|
| Social Stigma | 1 | 2020 | 701 | 0.110 |
Why?
|
| Adult | 12 | 2023 | 214035 | 0.110 |
Why?
|
| Cavernous Sinus | 1 | 2013 | 125 | 0.110 |
Why?
|
| Vasoconstriction | 1 | 2014 | 597 | 0.100 |
Why?
|
| Recurrence | 3 | 2022 | 8343 | 0.100 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 203 | 0.090 |
Why?
|
| Female | 15 | 2023 | 380197 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 12961 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2886 | 0.090 |
Why?
|
| Growth Cones | 1 | 2010 | 117 | 0.090 |
Why?
|
| Myelin Proteins | 1 | 2010 | 215 | 0.090 |
Why?
|
| Posterior Horn Cells | 1 | 2010 | 87 | 0.090 |
Why?
|
| Neural Inhibition | 2 | 2010 | 602 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2010 | 2915 | 0.080 |
Why?
|
| Humans | 20 | 2023 | 744220 | 0.080 |
Why?
|
| Prednisone | 1 | 2013 | 1575 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2108 | 0.080 |
Why?
|
| Male | 10 | 2022 | 350027 | 0.080 |
Why?
|
| Pruritus | 1 | 2010 | 361 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 3328 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2013 | 1059 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2013 | 3913 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4929 | 0.060 |
Why?
|
| Interneurons | 1 | 2010 | 577 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4151 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1114 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 2732 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1789 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7730 | 0.060 |
Why?
|
| Glia Maturation Factor | 1 | 2022 | 15 | 0.060 |
Why?
|
| Cognition | 1 | 2020 | 6765 | 0.050 |
Why?
|
| Phenotype | 1 | 2020 | 16365 | 0.050 |
Why?
|
| Colchicine | 1 | 2023 | 243 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2022 | 199 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10949 | 0.050 |
Why?
|
| Axons | 1 | 2008 | 1686 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 40063 | 0.050 |
Why?
|
| Risk Factors | 2 | 2017 | 72280 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77426 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 29050 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 40559 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17449 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1531 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2010 | 1152 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3176 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 126 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 547 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2010 | 385 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9335 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 261 | 0.020 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2008 | 26 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3567 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 418 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2008 | 562 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2008 | 464 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23404 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 279 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2726 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1423 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63119 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2010 | 19227 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1731 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 1422 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2010 | 1809 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3846 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5881 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.010 |
Why?
|
| Mice | 3 | 2010 | 81178 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 14556 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77679 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 24273 | 0.010 |
Why?
|
| Animals | 3 | 2010 | 168788 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 5709 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163253 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 56436 | 0.000 |
Why?
|